The study also includes only veterans with type 2 diabetes, not the general population
10.1080/02699052.2019.1587000 Summary Keywords stroke, GLP-1, GLP-1R agonists, neuroprotection, diabetes Citation Yang X, Qiang Q, Li N, Feng P, Wei W and Hlscher C (2022) Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research
Buyer Pain Points This Product Helps Solve
For those seeking verified information, medical and research-based platforms like PubMed or Healthline provide reliable insights into its science
Many patients who hit a plateau also realize they may need to refine their technique or expectations
May 8, 2026 Alzheimer's, Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Neurology, Therapies, Type 2 Diabetes, Type 2 Diabetes 4,716 views What if a medication designed to lower blood sugar could also help protect the brain